MEDCISION
DEAD

Serial Number

85563050

Owner

BioLife Solutions, Inc.

Attorney

Garth E. Coviello

First Use Date

Jan 16, 2017

Filing Date

Mar 7, 2012

Add to watchlist:

No watchlists yet
View on USPTO

MEDCISION Trademark

Serial Number: 85563050 • Registration: 5151370

MEDCISION is a trademark filed by BioLife Solutions, Inc. on March 7, 2012. The trademark is classified under Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

BioLife Solutions, Inc. (35 trademarks)

3303 MONTE VILLA PARKWAY
BOTHELL, WA 98021

Entity Type: 03

ASTERO BIO CORPORATION (5 trademarks)

3475 EDISON WAY
MENLO PARK, CA 94025

Entity Type: 03

Biocision, LLC (18 trademarks)

775 E. Blithedale Avenue, Suite 203
Mill Valley, CA 94941

Entity Type: 16

Trademark Details

Filing Date

March 7, 2012

Registration Date

February 28, 2017

First Use Anywhere

January 16, 2017

First Use in Commerce

January 16, 2017

Published for Opposition

November 26, 2013

Cancellation Date

September 8, 2023

Goods & Services

Medical apparatus, namely, integrated and standardized systems consisting primarily of medical sample tubes, pipettes and pipette tips, sample plates for bacterial, yeast and tissue culture, glassware for reagent storage and use, electrophoresis apparatuses for medical use, separation columns, HPLC apparatus for small molecule detection, separation and isolation, centrifuges, agarose gels, growth medium, precast SDS-PAGE protein gels for small molecule detection, separation and isolation, gel cassettes and combs for use with SDS-PAGE and agarose gels, enzyme-linked immunosorbent assays, PCR and RT-PCR apparatus for amplification of DNA, DNA microarrays, freezer apparatuses for cryogenic preservation of tissue samples, cryogenic transfer and storage apparatuses, thermal management apparatuses for regulating and maintaining a desired temperature of tissue samples, cold chain logistics apparatuses for ensuring an unbroken series of storage and distribution activities which maintain a given temperature range of tissue samples, apparatuses for freezing and thawing cells, viruses, microorganisms, bacterium, tissues, vaccines, blood, blood products, and cold chain logistics, cell and stem cell therapy apparatuses for isolating, culturing, freezing, preserving and administering cell and stem cell tissues, spectrometers, and chromatography systems consisting of hydrophobic interaction chromatography, ion exchange chromatography, affinity chromatography, metal binding, and immunoaffinity chromotography for collection, stabilization, purification and analysis of proteins, cells, RNA, microRNA, DNA and biomarkers from blood, bone marrow and tissue specimens for clinical and medical diagnostic use; Preanalytical systems consisting primarily of syringes, needles, catheters, petri dishes, sample tubes, test tube rockers, vacuum sample tubes, lancets, glassware for reagent storage and use, intravenous tubing, intravenous bags, urine collection containers, pipettes and pipette tips, syringes, sample plates, electrophoresis apparatuses for medical use, separation columns, HPLC apparatuses for small molecule detection, separation and isolation, centrifuges, agarose gels, growth medium, precast SDS-PAGE protein gels for small molecule detection, separation and isolation, gel cassettes and combs for use with SDS-PAGE and agarose gels, enzyme-linked immunosorbent assays, PCR and RT-PCR apparatuses for amplification of DNA, DNA microarrays, spectrometers, and chromatography systems, namely, hydrophobic interaction chromatography, ion exchange chromatography, affinity chromatography, metal binding, and immunoaffinity chromotography for molecular medical diagnostic uses; Medical apparatus for analyzing clinically relevant biomarkers for diagnosing or treating cancer, inflammatory bowel disease, Crohn's disease, Parkinson's disease, HIV, rheumatoid arthritis, obesity, Alzheimer's disease, Huntington's disease, Celiac disease, heart function, cardiovascular disease, lung disease, cholesterol, diabetes, nutritional deficiencies, aging, and chronic kidney disease; Medical kits consisting of integrated and standardized systems consisting primarily of medical sample tubes, pipettes and pipette tips, sample plates for bacterial, yeast and tissue culture, glassware for reagent storage and use, electrophoresis apparatuses for medical use, separation columns, HPLC apparatus for small molecule detection, separation and isolation, centrifuges, agarose gels, growth medium, precast SDS-PAGE protein gels for small molecule detection, separation and isolation, gel cassettes and combs for use with SDS-PAGE and agarose gels, enzyme-linked immunosorbent assays, PCR and RT-PCR apparatus for amplification of DNA, DNA microarrays, freezer apparatuses for cryogenic preservation of tissue samples, cryogenic transfer and storage apparatuses, thermal management apparatuses for regulating and maintaining a desired temperature of tissue samples, cold chain logistics apparatuses for ensuring an unbroken series of storage and distribution activities which maintain a given temperature range of tissue samples, apparatuses for freezing and thawing cells, viruses, microorganisms, bacterium, tissues, vaccines, blood, blood products, and cold chain logistics, cell and stem cell therapy apparatuses for isolating, culturing, freezing, preserving and administering cell and stem cell tissues, spectrometers, and chromatography systems consisting of hydrophobic interaction chromatography, ion exchange chromatography, affinity chromatography, metal binding, and immunoaffinity chromotography for collection, stabilization, purification and analysis of proteins, cells, RNA, microRNA, DNA and biomarkers from blood, bone marrow and tissue specimens for clinical and medical diagnostic use; Medical devices for collection, stabilization, purification and analysis of proteins, cells, RNA, microRNA, DNA and biomarkers from blood, bone marrow and tissue specimens, and software sold as a unit therewith for clinical and medical diagnostic use

Filing History

CANCELLED SEC. 8 (6-YR)
Sep 8, 2023 C8..
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jul 27, 2022 ASGN
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 28, 2022 REM1
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 26, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 26, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 26, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 26, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 26, 2020 COAR
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 27, 2019 ASGN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 14, 2017 TCCA
REGISTERED-PRINCIPAL REGISTER
Feb 28, 2017 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 27, 2017 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 26, 2017 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jan 24, 2017 SUPC
USE AMENDMENT FILED
Jan 19, 2017 IUAF
TEAS STATEMENT OF USE RECEIVED
Jan 19, 2017 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 29, 2016 EXRA
SOU EXTENSION 5 GRANTED
Jul 28, 2016 EX5G
SOU EXTENSION 5 FILED
Jul 20, 2016 EXT5
SOU TEAS EXTENSION RECEIVED
Jul 20, 2016 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 20, 2016 TCCA
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Feb 2, 2016 EXRA
SOU EXTENSION 4 GRANTED
Feb 1, 2016 EX4G
SOU EXTENSION 4 FILED
Jan 21, 2016 EXT4
SOU TEAS EXTENSION RECEIVED
Jan 21, 2016 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Jul 21, 2015 EXRA
SOU EXTENSION 3 GRANTED
Jul 20, 2015 EX3G
SOU EXTENSION 3 FILED
Jul 13, 2015 EXT3
SOU TEAS EXTENSION RECEIVED
Jul 13, 2015 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Mar 3, 2015 EXRA
SOU EXTENSION 2 GRANTED
Feb 28, 2015 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 27, 2015 AITU
SOU EXTENSION 2 FILED
Jan 14, 2015 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 14, 2015 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Jul 23, 2014 EXRA
SOU EXTENSION 1 GRANTED
Jul 21, 2014 EX1G
SOU EXTENSION 1 FILED
Jul 21, 2014 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 21, 2014 EEXT
NOA MAILED - SOU REQUIRED FROM APPLICANT
Jan 21, 2014 NOAM
PUBLISHED FOR OPPOSITION
Nov 26, 2013 PUBO
NOTICE OF PUBLICATION
Nov 6, 2013 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 23, 2013 PREV
ASSIGNED TO LIE
Oct 23, 2013 ALIE
EXAMINERS AMENDMENT MAILED
Oct 8, 2013 CNEA
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 8, 2013 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 8, 2013 XAEC
EXAMINERS AMENDMENT -WRITTEN
Oct 8, 2013 CNEA
CONTINUATION OF FINAL REFUSAL MAILED
Sep 9, 2013 CNCF
ACTION CONTINUING A FINAL - COMPLETED
Sep 6, 2013 CNCF
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 15, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 14, 2013 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 14, 2013 ERFR
CONTINUATION OF FINAL REFUSAL MAILED
Jul 15, 2013 CNCF
ACTION CONTINUING A FINAL - COMPLETED
Jul 15, 2013 CNCF
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 20, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 20, 2013 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jun 20, 2013 ERFR
FINAL REFUSAL MAILED
Dec 20, 2012 CNFR
FINAL REFUSAL WRITTEN
Dec 20, 2012 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 19, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 18, 2012 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 18, 2012 TROA
NON-FINAL ACTION MAILED
Jun 18, 2012 CNRT
NON-FINAL ACTION WRITTEN
Jun 15, 2012 CNRT
ASSIGNED TO EXAMINER
Jun 15, 2012 DOCK
NOTICE OF PSEUDO MARK MAILED
Mar 14, 2012 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 13, 2012 NWOS
NEW APPLICATION ENTERED
Mar 10, 2012 NWAP